Fibrosis in Metabolic Organs due to Diabetes

Diabetes is linked to the development of fibrosis in several key metabolic organs, such as the liver, pancreas, and kidneys. The persistent high blood sugar levels and chronic inflammation activate fibrogenic pathways, resulting in the accumulation of extracellular matrix components and subsequent scarring of the affected tissues. In the liver, this fibrosis can advance to conditions like non-alcoholic fatty liver disease and cirrhosis. Similarly, fibrosis in the pancreas can impair insulin secretion and disrupt beta-cell function, while renal fibrosis can worsen diabetic nephropathy, ultimately leading to decreased kidney function. Targeting the mechanisms involved in fibrogenesis may provide innovative strategies for preventing and managing complications associated with diabetes.